A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder

References

• Schaffer J, Fantl JA. Urogenital effects of the menopause. Baillière’s Clin Obstet Gynaecol 1996; 10: 401–17.
   Google Scholar
• Batra SC, Iosif CS. Female urethra: a target for estrogen action. JUrol 1983; 129: 418–20.
   Google Scholar
• Blakeman PJ, Hilton P, Bulmer JN. Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int 2000; 86: 32–8.
   Google Scholar
• Abrams P, Wein AJ. The overactive bladder. A widespread and treatable condition. Stockholm: Erik Sparre Medical AB, 1998.
   Google Scholar
• Bachmann G. Urogenital ageing: an old problem newly recognized. Maturitas 1995; 22: S1–S5.
   Google Scholar
• Pandit L, Ouslander JG. Postmenopausal vaginal atrophy and atrophic vaginitis. Am J Med Sci 1997; 314: 228–31.
   PubMed Web of Science ®Google Scholar
• Versi E, Cardozo L, Studd J, Brincat M, Cooper D. Urinary disorders and the menopause. Menopause 1995; 2: 89–95.
   Google Scholar
• Thomas TM, Plymat KR, Blannin J. Prevalence of urinary incontinence. BMJ 1980; 281: 1243–5.
   Google Scholar
• Versi E, Cardozo LD. Estrogens and lower urinary tract function. In: Studd JWW, Whitehead MI, eds. The Menopause. Oxford: Blackwell Science, 1988: 76–84.
   Google Scholar
• Brown JS, Grady D, Ouslander JG, Herzog AR, Varner RE, Posner SF. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart Estrogen/Progestin Replacement Study (HERS) Resesrch Group. Obstet Gynecol 1999; 94: 66–70.
   PubMed Web of Science ®Google Scholar
• Fantl JA, Cardozo L, McClish DK. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1994; 83: 12–8.
   Google Scholar
• Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogential Therapy Committee. Obstet Gynecol 1998; 92: 722–7.
   Google Scholar
• Cardozo L, Lose G, McClish D, Versi E, de Koning Gans H. A systematic review of estrogens for recurrent urinary tract infections: third report of the hormones and urogenital therapy (HUT) committee. Int Urogynecol J Pelvic Floor Dysfunct 2001; 12: 15–20.
   Google Scholar
• Lose G, Englev E. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. Br J Obstet Gynaecol 2000; 107: 1029–34.
   Google Scholar
• Walter S, Wolf H, Barlebo H, Jensen HK. Urinary incontinence in postmenopausal women treated with estrogens: a doubleblind clinical trial. Urol Int 1978; 33: 135–43.
   Google Scholar
• Samsioe G, Jansson I, Mellström D, Svanborg A. Occurrence, nature and treatment of urinary incontinence in a 70-year-old female population. Maturitas 1985; 7: 335–42.
   Google Scholar
• Molander U, Milsom I, Ekelund P, Mellström D, Eriksson O. Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post-menopause. Maturitas 1990; 12: 113–20.
   Google Scholar
• Enzelsberger H, Kurz CH, Schatten CH, Huber J. Effects of intravaginal application of oestriol tablets in women with urge incontinence. Geburtshilfe Frauenheilkd 1991; 51: 834–8.
   PubMed Web of Science ®Google Scholar
• Cardozo L, Rekers H, Tapp A, Barnick C, Shepherd A, Schussler B et al. Oestriol in the treatment of postmenopausal urgency: a multicentre study. Maturitas 1993; 18: 47–53.
   PubMed Web of Science ®Google Scholar
• Kurz C, Nagele F, Sevelda P, Enzelsberger H. Intravesikal application of oestriol as therapy of sensory urge incontinence – a prospective study. Geburtshilfe Frauenheilkd 1993; 53: 535–8.
   Google Scholar
• Blom MW, Sommers DK. The effects of an estradiol transdermal therapeutic system, alone and in combination with naproxen, on urge incontinence in elderly women: a pilot study. Current Therapeutic Res 1995; 56: 1100–4.
   Google Scholar
• Fantl JA, Bump RC, Robinson D, McClish DK, Wyman JF, The Continence Program for Women Research Group. Efficacy of estrogen supplementation in the treatment of urinary incontinence. Obstet Gynecol 1996; 88: 745–9.
   Google Scholar
• Abel I. Elektrostimulation Og Lokal Østrogenterapi Til Behandling Af Urininkontinens Hos Postmenopausale Kvinder. S. København Universitet 1997.
   Google Scholar
• Hextall A. The effect of oestrogen and the menopause on the female lower urinary tract. MD Thesis. University of London 2001.
   Google Scholar
• Cardozo LD, Wise BG, Benness CJ. Vaginal oestradiol for the treatment of lower urinary tract symptoms in postmenopausal women – a double-blind placebo-controlled study. J Obstet Gynecol 2001; 21: 383–5.
   Google Scholar
• Eriksen BC. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring®) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999; 180: 1072–9.
   PubMed Web of Science ®Google Scholar
• Stouffer SA, Suchman EA, DeVinney LC, Star SA, Williams RM. The American Soldier: adjustment during army life. Vol. 1. Princeton, NJ: Princeton University Press, 1949.
   Google Scholar
• Rosenthal R. Meta-Analytic Procedures for Social Research. Vol. 6. Beverly Hills, California: Sage Publications, 1984.
   Google Scholar
• Wein AJ, Roberts RW. Overactive bladder survey. Evaluates the extent of symptoms in family doctor setting. Fam Urol 2000; 5: 7–8.
   Google Scholar
• Naylor CD. Meta-analysis and the meta-epidemiology of clinical research. BMJ 1997; 315: 617–9.
   PubMed Web of Science ®Google Scholar